313
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Application of a TNF-alpha-inhibitor into the scala tympany after cochlear electrode insertion trauma in guinea pigs: Preliminary audiologic results

, , , &
Pages 810-816 | Received 12 Oct 2013, Accepted 15 Jun 2014, Published online: 14 Oct 2014

References

  • Baek M.J., Park H.M., Johnson J.M., Altuntas C.Z., Jane-Wit D. et al. 2006. Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss. J Immunol, 177, 4203–4210.
  • Bas E., Dinh C.T., Garnham C., Polak M. & van de Water T.R. 2012a. Conservation of hearing and protection of hair cells in cochlear implant patients with residual hearing. Anat Rec (Hoboken), 295, 1909–1927.
  • Bas E., Gupta C. & van de Water T.R. 2012b. A novel organ of corti explant model for the study of cochlear implantation trauma. Anat Rec (Hoboken), 295, 1944–1956.
  • Carlson M.L., Driscoll C.L., Gifford R.H., Service G.J., Tombers N.M. et al. 2011. Implications of minimizing trauma during conventional cochlear implantation. Otol Neurotol, 32, 962–968.
  • Chang A., Eastwood H., Sly D., James D., Richardson R. et al. 2009. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res, 255, 67–72.
  • Duan Y.Y., Clark G.M. & Cowan R.S. 2004. A study of intra-cochlear electrodes and tissue interface by electrochemical impedance methods in vivo. Biomaterials, 25, 3813–3828.
  • Eastwood H., Chang A., Kel G., Sly D., Richardson R. et al. 2010a. Round window delivery of dexamethasone ameliorates local and remote hearing loss produced by cochlear implantation into the second turn of the guinea pig cochlea. Hear Res, 265, 25–29.
  • Eastwood H., Pinder D., James D., Chang A., Galloway S. et al. 2010b. Permanent and transient effects of locally delivered n-acetyl cysteine in a guinea pig model of cochlear implantation. Hear Res, 259, 24–30.
  • Enticott J.C., Eastwood H.T., Briggs R.J., Dowell R.C. & O'Leary S.J. 2011. Methylprednisolone applied directly to the round window reduces dizziness after cochlear implantation: A randomized clinical trial. Audiol Neurootol, 16, 289–303.
  • Eshraghi A.A., Adil E., He J., Graves R., Balkany T.J. et al. 2007a. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol, 28, 842–849.
  • Eshraghi A.A., Gupta C., van de Water T.R., Bohorquez J.E., Garnham C. et al. 2013. Molecular mechanisms involved in cochlear implantation trauma and the protection of hearing and auditory sensory cells by inhibition of c-Jun-N-terminal kinase signaling. Laryngoscope, 123 Suppl. 1, S1–14.
  • Eshraghi A.A., He J., Mou C.H., Polak M., Zine A. et al. 2006. D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma. Otol Neurotol, 27, 504–511.
  • Eshraghi A.A., Hoosien G., Ramsay S., Dinh C.T., Bas E. et al. 2010. Inhibition of the JNK signal cascade conserves hearing against electrode insertion trauma-induced loss. Cochlear Implants Int, 11 Suppl. 1, 104–109.
  • Eshraghi A.A., Wang J., Adil E., He J., Zine A. et al. 2007b. Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity. Hear Res, 226, 168–177.
  • Greenwood D.D. 1990. A cochlear frequency-position function for several species: 29 years later. J Acoust Soc Am, 87, 2592–2605.
  • Haake S.M., Dinh C.T., Chen S., Eshraghi A.A. & van de Water T.R. 2009. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Hear Res, 255, 22–32.
  • Havenith S., Lammers M.J., Tange R.A., Trabalzini F., della Volpe A. et al. 2013. Hearing preservation surgery: Cochleostomy or round window approach? A systematic review. Otol Neurotol, 34, 667–674.
  • Helbig S., Baumann U., Hey C. & Helbig M. 2011. Hearing preservation after complete cochlear coverage in cochlear implantation with the free-fitting FLEXSOFT electrode carrier. Otol Neurotol, 32, 973–979.
  • Hoang K.N., Dinh C.T., Bas E., Chen S., Eshraghi A.A. et al. 2009. Dexamethasone treatment of naive organ of Corti explants alters the expression pattern of apoptosis-related genes. Brain Res, 1301, 1–8.
  • Ihler F., Sharaf K., Bertlich M., Strieth S., Reichel C.A. et al. 2013. Etanercept prevents decrease of cochlear blood flow dose-dependently caused by tumour necrosis factor alpha. Ann Otol Rhinol Laryngol, 122, 468–473.
  • Infante E.B., Channer G.A., Telischi F.F., Gupta C., Dinh J.T. et al. 2012. Mannitol protects hair cells against tumour necrosis factor alpha-induced loss. Otol Neurotol, 33, 1656–1663.
  • James D.P., Eastwood H., Richardson R.T. & O'Leary S.J. 2008. Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation. Audiol Neurootol, 13, 86–96.
  • Jewett D.L. & Williston J.S. 1971. Auditory-evoked far fields averaged from the scalp of humans. Brain, 94, 681–696.
  • Jia H., Wang J., Francois F., Uziel A., Puel J.L. et al. 2013. Molecular and cellular mechanisms of loss of residual hearing after cochlear implantation. Ann Otol Rhinol Laryngol, 122, 33–39.
  • Maini S., Lisnichuk H., Eastwood H., Pinder D., James D. et al. 2009. Targeted therapy of the inner ear. Audiol Neurootol, 14, 402–410.
  • Manrique M., Picciafuoco S., Manrique R., Sanhueza I., Dominguez P. et al. 2014. Atraumaticity study of two cochlear implant electrode arrays. Otol Neurotol, 35, 619–628.
  • Mohler K.M., Torrance D.S., Smith C.A., Goodwin R.G., Stremler K.E. et al. 1993. Soluble tumour necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol, 151, 1548–1561.
  • Pau H.W., Just T., Bornitz M., Lasurashvilli N. & Zahnert T. 2007. Noise exposure of the inner ear during drilling a cochleostomy for cochlear implantation. Laryngoscope, 117, 535–540.
  • Radeloff A., Unkelbach M.H., Tillein J., Braun S., Helbig S. et al. 2007. Impact of intrascalar blood on hearing. Laryngoscope, 117, 58–62.
  • Rajan G.P., Kuthubutheen J., Hedne N. & Krishnaswamy J. 2012. The role of preoperative, intratympanic glucocorticoids for hearing preservation in cochlear implantation: A prospective clinical study. Laryngoscope, 122, 190–195.
  • Richard C., Fayad J.N., Doherty J. & Linthicum Jr. F.H. 2012. Round window versus cochleostomy technique in cochlear implantation: Histologic findings. Otol Neurotol, 33, 1181–1187.
  • Richardson R.T., Wise A.K., Andrew J.K. & O'Leary S.J. 2008. Novel drug delivery systems for inner ear protection and regeneration after hearing loss. Expert Opin Drug Deliv, 5, 1059–1076.
  • Roland P.S. & Wright C.G. 2006. Surgical aspects of cochlear implantation: Mechanisms of insertional trauma. Adv Otorhinolaryngol, 64, 11–30.
  • Satoh H., Firestein G.S., Billings P.B., Harris J.P. & Keithley E.M. 2002. Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope, 112, 1627–1634.
  • Satoh H., Firestein G.S., Billings P.B., Harris J.P. & Keithley E.M. 2003. Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol, 4, 139–147.
  • Scarpidis U., Madnani D., Shoemaker C., Fletcher C.H., Kojima K. et al. 2003. Arrest of apoptosis in auditory neurons: Implications for sensorineural preservation in cochlear implantation. Otol Neurotol, 24, 409–417.
  • Skarzynski H., Lorens A., Matusiak M., Porowski M., Skarzynski P.H. et al. 2014. Cochlear implantation with the Nucleus Slim Straight Electrode in subjects with residual low-frequency hearing. Ear Hear.
  • Souter M., Eastwood H., Marovic P., Kel G., Wongprasartsuk S. et al. 2012. Systemic immunity influences hearing preservation in cochlear implantation. Otol Neurotol, 33, 532–538.
  • Toubi E., Ben-David J., Kessel A., Halas K., Sabo E. et al. 2004. Immune-mediated disorders associated with idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol, 113, 445–449.
  • van de Water T.R., Abi Hachem R.N., Dinh C.T., Bas E., Haake S.M. et al. 2010a. Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: Molecular and genetic mechanisms. Cochlear Implants Int, 11, Suppl. 1, 42–55.
  • van de Water T.R., Dinh C.T., Vivero R., Hoosien G., Eshraghi A.A. et al. 2010b. Mechanisms of hearing loss from trauma and inflammation: Otoprotective therapies from the laboratory to the clinic. Acta Otolaryngol, 130, 308–311.
  • Wang X., Truong T., Billings P.B., Harris J.P. & Keithley E.M. 2003. Blockage of immune-mediated inner-ear damage by etanercept. Otol Neurotol, 24, 52–57.
  • Zou J., Pyykko I., Sutinen P. & Toppila E. 2005. Vibration induced hearing loss in guinea pig cochlea: Expression of TNF-alpha and VEGF. Hear Res, 202, 13–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.